TriReme Medical Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • TriReme Medical's estimated annual revenue is currently $6.8M per year.(i)
  • TriReme Medical's estimated revenue per employee is $251,000

Employee Data

  • TriReme Medical has 27 Employees.(i)
  • TriReme Medical grew their employee count by -18% last year.

TriReme Medical's People

NameTitleEmail/Phone
1
VP RA/QAReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
3
Director Research and DevelopmentReveal Email/Phone
4
Quality Assurance LeadReveal Email/Phone
5
Field Senior Clinical Research AssociateReveal Email/Phone
6
Clinical Research Associate IIReveal Email/Phone
7
District Sales ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is TriReme Medical?

TriReme Medical, LLC is a medical device company dedicated to developing, manufacturing and distributing advanced therapeutic solutions for the treatment of complex vascular disease. Addressing specific unmet clinical needs, TriReme is working closely with thought leaders and scientists around the world to offer physicians new and differentiated devices to improve outcomes in complex peripheral and coronary interventions. QT Vascular Ltd. is the parent holding company of TriReme Medical, LLC. QT Vascular is based in Singapore. TriReme Medical LLC, a US subsidiary, is based in Pleasanton, California. QT Vascular was listed on the Catalist Board of the Singapore Exchange Securities Trading Limited on 29 April 2014.

keywords:N/A

N/A

Total Funding

27

Number of Employees

$6.8M

Revenue (est)

-18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TriReme Medical News

2022-03-30 - Study shows superiority of Chocolate Touch device for opening blocked arteries in the leg

... covered in medicine that helps prevent blockage from reoccurring. ... The study was funded by TriReme Medical, maker of the device.

2022-03-30 - Sweet Success for Chocolate Touch DCB in Femoropopliteal ...

The Chocolate Touch DCB (TriReme Medical) emerged as decisively ... DO, MPH, PhD, Case Western Reserve School of Medicine, Cleveland.

2022-03-30 - Chocolate Touch DCB successful in head-to-head trial in ...

The second-generation Chocolate Touch DCB (TriReme Medical) met both noninferiority endpoints for safety and efficacy and was more effective...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.7M278%N/A
#2
$3.9M27N/AN/A
#3
$5.4M278%N/A
#4
$6.8M274%N/A
#5
$2.2M27-16%N/A